The following is an exciting announcement from an FSR partner, Boehringer Ingelheim – see the release on their website here. Boehringer Ingelheim Begins Phase 2 Clinical Trial of a Targeted Therapy to Help People with Severe Respiratory Illness from COVID-19...
COVID-19 has changed our world. As of October 1, 2020, the Johns Hopkins University Coronavirus Resource Center reported over 35.5 million individuals worldwide have been infected with COVID-19, including over 7 million in the United States. There are about 200,000...
The Foundation for Sarcoidosis Research, the leading nonprofit organization dedicated to advancing research and improving care for individuals living with sarcoidosis, announces Mary McGowan as the organization’s first-ever Chief Executive Officer. With more...
This year, the Team KISS Walk/Run is going completely virtual. This means that participants worldwide can join and complete any route of their choosing – whether that is your neighborhood, favorite park, local trail, or even from your own home. See below for more...
